EDIL3 and cancer: Studies have shown that the expression of Del-1 is upregulated in cancer cells; αvβ3, αvβ5, and their ligands Del-1 and L1-CAM (CD171) play essential roles in the process of cancer cell adhesion at the primary site [25, 26].